Expression status of PD-L1 and B7-H3 in mesothelioma.

Matsumura, Eiji; Kajino, Kazunori; Abe, Masaaki; Ohtsuji, Naomi; Saeki, Harumi; Hlaing, May Thinzar; Hino, Okio

Matsumura, Eiji; Kajino, Kazunori; Abe, Masaaki; Ohtsuji, Naomi; Saeki, Harumi; Hlaing, May Thinzar; Hino, Okio.

Afiliação

Matsumura E; Departments of Pathology and Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kajino K; Department of Oncology Medical Science, Daiichi Sankyo Co., Ltd, Tokyo, Japan.
Abe M; Departments of Pathology and Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ohtsuji N; Departments of Pathology and Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Saeki H; Departments of Pathology and Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hlaing MT; Departments of Pathology and Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hino O; Departments of Pathology and Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Pathol Int ; 70(12): 999-1008, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33027549

Assuntos

Antígenos B7/metabolismo; Antígeno B7-H1/metabolismo; Mesotelioma; Idoso; Biomarcadores Tumorais/metabolismo; Feminino; Humanos; Imuno-Histoquímica; Masculino; Mesotelioma/metabolismo; Mesotelioma/patologia; Mesotelioma Maligno/metabolismo; Mesotelioma Maligno/patologia; Pessoa de Meia-Idade

Palavras-chave

B7-H1; B7-H3; PD-L1; mesothelioma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos B7 / Antígeno B7-H1 / Mesotelioma Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google